Integrated systems biology approach identifies gene targets for endothelial dysfunction

Area of Science:

• Cardiovascular Biology
• Systems Biology
• Molecular Medicine

Background:

• Endothelial dysfunction (ED) is a critical factor in cardiovascular disease development and progression.
• Current therapeutic targets for ED are limited due to poor understanding of its molecular mechanisms.

Purpose of the Study:

• To identify potential therapeutic targets for endothelial dysfunction using a systems biology approach.
• To uncover key genes and molecular networks involved in ED pathogenesis.

Main Methods:

• Integrated multi-omics data analysis, siRNA screening, high-content imaging, and network analysis.
• Prioritization of ED-related genes and construction of pro- and anti-ED networks.

Main Results:

• Silencing 26 genes exacerbated ED phenotypes, revealing a pro-ED network linked to inflammation.
• Silencing 31 genes ameliorated ED phenotypes, identifying an anti-ED network associated with hypoxia and angiogenesis.
• Drug screening confirmed siRNA trends and highlighted DUSP1, IL6, and CCL2 as potential ED targets.

Conclusions:

• Integrated systems biology approaches are effective for discovering disease-specific drug targets for endothelial dysfunction.
• The identified pro- and anti-ED networks offer insights into ED mechanisms and potential therapeutic strategies.